MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance

International Journal of Cancer

Volumn 137, Issue 5, 2015, Pages 1021-1034

  Suh, Yae Eun ^a   Raulf, Nina ^a   Gäken, Joop ^a   Lawler, Katherine ^a   Urbano, Teresa Guerrero ^b   Bullenkamp, Jessica ^a   Gobeil, Stéphane ^c   Huot, Jacques ^d   Odell, Eddy ^a   Tavassoli, Mahvash ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c LAVAL UNIVERSITY   (Canada)

^d Université Laval   (Canada)

Author keywords

annexin A1; biomarkers; head and neck squamous cell carcinoma; MicroRNA 196a; radiosensitivity

Indexed keywords

HISTONE H2AX; LIPOCORTIN 1; MICRORNA; MICRORNA 196A; UNCLASSIFIED DRUG; MIRN196 MICRORNA, HUMAN;

ARTICLE; CANCER RADIOTHERAPY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REPRESSION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; GENE TARGETING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; LUCIFERASE ASSAY; MTT ASSAY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TARGETING; RADIOSENSITIVITY; WESTERN BLOTTING; CELL MOTION; GENETICS; HEAD AND NECK TUMOR; HEK293 CELL LINE; METABOLISM; PATHOLOGY; PROGNOSIS; RADIATION DOSE; RADIATION RESPONSE; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANNEXIN A1; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; HEAD AND NECK NEOPLASMS; HEK293 CELLS; HUMANS; MICRORNAS; PROGNOSIS; RADIATION TOLERANCE;

EID: 84931576429     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29397     Document Type: Article

References (49)

1. Suh Y, Amelio I, Guerrero Urbano T, Tavassoli M,. Clinical update on cancer: molecular oncology of head and neck cancer. Cell Death Dis 2014; 5: e1018.
2. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB,. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-98.
3. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
4. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR,. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-8.
5. Chen CZ,. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 2005; 353: 1768-71.
6. Shiiba M, Shinozuka K, Saito K, Fushimi K, Kasamatsu A, Ogawara K, Uzawa K, Ito H, Takiguchi Y, Tanzawa H,. MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma. Br J Cancer 2013; 108: 1817-21.
7. Liu CJ, Tsai MM, Tu HF, Lui MT, Cheng HW, Lin SC,. miR-196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas. Ann Surg Oncol 2013; 20(Suppl 3): S406-14.
8. Yang G, Han D, Chen X, Zhang D, Wang L, Shi C, Zhang W, Li C, Liu H, Kang J, Peng F, Liu Z, Qi J, Gao X, Ai J, Zhao S,. MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IkappaBalpha both in vitro and in vivo. Neuro Oncol 2014; 16: 652-61.
9. Hou T, Ou J, Zhao X, Huang X, Huang Y, Zhang Y,. MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1. Br J Cancer 2014; 110: 1260-8.
10. Huang F, Tang J, Zhuang X, Zhuang Y, Cheng W, Chen W, Yao H, Zhang S,. MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha. PLoS One 2014; 9: e87897.
11. Sun M, Liu XH, Li JH, Yang JS, Zhang EB, Yin DD, Liu ZL, Zhou J, Ding Y, Li SQ, Wang ZX, Cao XF, De W,. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1). Mol Cancer Ther 2012; 11: 842-52.
12. Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A, Young BD,. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 2007; 21: 912-6.
13. Braig S, Mueller DW, Rothhammer T, Bosserhoff AK,. MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cell Mol Life Sci 2010; 67: 3535-48.
14. Mueller DW, Bosserhoff AK,. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. Int J Cancer 2011; 129: 1064-74.
15. Severino P, Bruggemann H, Andreghetto FM, Camps C, Klingbeil Mde F, de Pereira WO, Soares RM, Moyses R, Wunsch-Filho V, Mathor MB, Nunes FD, Ragoussis J, Tajara EH,. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation. BMC Cancer 2013; 13: 533
16. Luthra R, Singh RR, Luthra MG, Li YX, Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, Broaddus RR, Rashid A, Albarracin CT,. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008; 27: 6667-78.
17. Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy S, Swisher SG, Hofstetter WL, Rashid A, Luthra R,. MicroRNA-196a is a potential marker of progression during barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol 2009; 174: 1940-8.
18. Coskun E, von der Heide EK, Schlee C, Kuhnl A, Gokbuget N, Hoelzer D, Hofmann WK, Thiel E, Baldus CD,. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia. Leuk Res 2011; 35: 208-13.
19. Lim LH, Pervaiz S,. Annexin 1: the new face of an old molecule. FASEB J 2007; 21: 968-75.
20. Cheng SX, Tu Y, Zhang S,. FoxM1 promotes glioma cells progression by up-regulating Anxa1 expression. PLoS One 2013; 8: e72376
21. Liu YF, Zhang PF, Li MY, Li QQ, Chen ZC,. Identification of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma. Clin Exp Metastasis 2011; 28: 413-25.
22. Garcia Pedrero JM, Fernandez MP, Morgan RO, Herrero Zapatero A, Gonzalez MV, Suarez Nieto C, Rodrigo JP,. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 2004; 164: 73-9.
23. Zhang L, Yang X, Zhong LP, Zhou XJ, Pan HY, Wei KJ, Li J, Chen WT, Zhang ZY,. Decreased expression of annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma. J Oral Pathol Med 2009; 38: 362-70.
24. Zhu DW, Yang X, Yang CZ, Ma J, Liu Y, Yan M, Wang LZ, Li J, Zhang CP, Zhang ZY, Zhong LP,. Annexin A1 down-regulation in oral squamous cell carcinoma correlates to pathological differentiation grade. Oral Oncol 2013; 49: 542-50.
25. Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH, Herring J, Wang QH, Hu N, Linehan WM, Taylor PR, Liotta LA, Emmert-Buck MR, Petricoin EF. 3rd., Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 2000; 60: 6293-7.
26. Rodrigo JP, Garcia-Pedrero JM, Fernandez MP, Morgan RO, Suarez C, Herrero A,. Annexin A1 expression in nasopharyngeal carcinoma correlates with squamous differentiation. Am J Rhinol 2005; 19: 483-7.
27. Dunning MJ, Smith ML, Ritchie ME, Tavare S,. beadarray: R classes and methods for illumina bead-based data. Bioinformatics 2007; 23: 2183-4.
28. Smyth GK,. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article3
29. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and pawerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 1995; 57: 289-300.
30. Bouquet F, Muller C, Salles B,. The loss of gammaH2AX signal is a marker of DNA double strand breaks repair only at low levels of DNA damage. Cell Cycle 2006; 5: 1116-22.
31. Kluiver J, Gibcus JH, Hettinga C, Adema A, Richter MK, Halsema N, Slezak-Prochazka I, Ding Y, Kroesen BJ, van den Berg A,. Rapid generation of microRNA sponges for microRNA inhibition. PLoS One 2012; 7: e29275
32. Tsai MM, Wang CS, Tsai CY, Chen CY, Chi HC, Tseng YH, Chung PJ, Lin YH, Chung IH, Chen CY, Lin KH,. MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer. Cancer Lett 2014; 351: 222-31.
33. Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q,. MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med 2011; 15: 14-23.
34. Maschler S, Gebeshuber CA, Wiedemann EM, Alacakaptan M, Schreiber M, Custic I, Beug H,. Annexin A1 attenuates EMT and metastatic potential in breast cancer. EMBO Mol Med 2010; 2: 401-14.
35. Solito E, de Coupade C, Canaider S, Goulding NJ, Perretti M,. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 2001; 133: 217-28.
36. Debret R, El Btaouri H, Duca L, Rahman I, Radke S, Haye B, Sallenave JM, Antonicelli F,. Annexin A1 processing is associated with caspase-dependent apoptosis in BZR cells. FEBS Lett 2003; 546: 195-202.
37. Tabe Y, Jin L, Contractor R, Gold D, Ruvolo P, Radke S, Xu Y, Tsutusmi-Ishii Y, Miyake K, Miyake N, Kondo S, Ohsaka A, Nagaoka I, Andreeff M, Konopleva M,. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Cell Death Differ 2007; 14: 1443-56.
38. Zhang Z, Huang L, Zhao W, Rigas B,. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res 2010; 70: 2379-88.
39. Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E, Parente L,. Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells. Cell Death Differ 2005; 12: 1358-60.
40. Alldridge LC, Bryant CE,. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res 2003; 290: 93-107.
41. Alldridge LC, Harris HJ, Plevin R, Hannon R, Bryant CE,. The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. J Biol Chem 1999; 274: 37620-8.
42. Pepinsky RB, Sinclair LK,. Epidermal growth factor-dependent phosphorylation of lipocortin. Nature 1986; 321: 81-4.
43. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK, Milas L,. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002; 62: 7350-6.
44. Croxtall JD, Waheed S, Choudhury Q, An R, Flower RJ,. Nterminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation. Int J Cancer 1993; 54: 153-8.
45. Cheng TY, Wu MS, Lin JT, Lin MT, Shun CT, Huang HY, Hua KT, Kuo ML,. Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway. Cancer 2012; 118: 5757-67.
46. Cote MC, Lavoie JR, Houle F, Poirier A, Rousseau S, Huot J,. Regulation of vascular endothelial growth factor-induced endothelial cell migration by LIM kinase 1-mediated phosphorylation of annexin 1. J Biol Chem 2010; 285: 8013-21.
47. Pin AL, Houle F, Fournier P, Guillonneau M, Paquet ER, Simard MJ, Royal I, Huot J., Annexin-1-mediated endothelial cell migration and angiogenesis are regulated by VEGF-induced inhibition of miR-196a expression. J Biol Chem 2012; 287: 30541-51.
48. Weyd H, Abeler-Dorner L, Linke B, Mahr A, Jahndel V, Pfrang S, Schnolzer M, Falk CS, Krammer PH,. Annexin A1 on the surface of early apoptotic cells suppresses CD8+ T cell immunity. PLoS One 2013; 8: e62449.
49. Zeng GQ, Cheng AL, Tang J, Li GQ, Li MX, Qu JQ, Cao C, Liao L, Xiao ZQ,. Annexin A1: a new biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Med Hypotheses 2013; 81: 68-70.